Guangzhou Datai Bioengineering Technology, a unit of Daan Gene (SHE:002030), obtained a medical device registration certificate from China's National Medical Products Administration for its alpha-fetoprotein assay kit.
This kit is used to determine the content of alpha-fetoprotein in human serum or plasma samples.
The certificate is valid until Sept. 28, 2029, the diagnostic test kit maker said in a Sept. 30 disclosure on the Shenzhen bourse
Shares of the company jumped less than 7% at the close.
Price (RMB): ¥6.84, Change: ¥+0.42, Percent Change: +6.54%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.